Canada markets closed

Accuray Incorporated (ARAY)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
1.7400-0.1300 (-6.95%)
At close: 04:00PM EDT
1.9000 +0.16 (+9.20%)
After hours: 07:17PM EDT

Accuray Incorporated

1240 Deming Way
Madison, WI 53717-1954
United States
608 824 2800

IndustryMedical Devices
Full Time Employees1,024

Key Executives

NameTitlePayExercisedYear Born
Ms. Suzanne Winter M.B.A.President, CEO & Director1.02MN/A1963
Mr. Ali PervaizSenior VP & CFO, Interim Principal Accounting officer601.12kN/A1981
Mr. Michael HogeSenior Vice President of Global Operations540.12kN/A1967
Mr. Jesse ChewSenior VP, Chief Legal Officer & Company Secretary621.2kN/A1981
Mr. Sandeep ChalkeSenior VP & Chief Commercial Officer826.18kN/A1966
Mr. John M. DunnVice President, Chief Information & Security OfficerN/AN/AN/A
Beth KaplanPublic Relations DirectorN/AN/AN/A
Ms. Melanie GebauerVice President of Global Human ResourcesN/AN/AN/A
Mr. Juki HozumiPresident & GM of Japan RegionN/AN/AN/A
Mr. Jim DennisonSenior Vice President of Global Regulatory, Quality & Product DevelopmentN/AN/AN/A
Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.


Accuray Incorporated designs, develops, manufactures, and sells radiosurgery and radiation therapy systems for the treatment of tumors in the United States, Canada, Latin America, Australia, New Zealand, Europe, the Middle East, India, Africa, Japan, China, and rest of the Asia Pacific region. It offers the CyberKnife System, a robotic stereotactic radiosurgery and stereotactic body radiation therapy system used for the treatment of primary and metastatic tumors outside the brain, including tumors on or near the spine and in the breast, kidney, liver, lung, pancreas, and prostate. The company also provides the TomoTherapy System, including the Radixact System, which allows for integrated radiation treatment planning, delivery, and data management, enabling clinicians to deliver ultra-precise treatments to approximately 50 patients per day; iDMS data management system, a fully integrated treatment planning and data management systems; and Accuray precision treatment planning system, a treatment planning and data management systems. In addition, it offers post-contract customer support, installation, training, and other professional services. The company primarily markets its products directly to customers, including hospitals and stand-alone treatment facilities through its sales organization, as well as to customers through sales agents and group purchasing organizations in the United States; and to customers directly and through distributors and sales agents internationally. Accuray Incorporated was incorporated in 1990 and is headquartered in Madison, Wisconsin.

Corporate Governance

Accuray Incorporated’s ISS Governance QualityScore as of June 1, 2024 is 3. The pillar scores are Audit: 5; Board: 1; Shareholder Rights: 5; Compensation: 3.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.